“Stable disease” means your treatments are causing your tumor(s) to either not grow or shrink while no new tumors are developing. If you have stable disease, you may wonder how often you should receive monitoring. Although clear guidelines have not been established, monitoring may include imaging, blood tests, and biomarker tests. Types of monitoring and frequency may also depend on your tumor biomarkers, such as hormone receptor status and HER2 status.
Read below to learn about stable disease and current research on monitoring MBC treatment response.
Introduction to Stable Disease
- VeryWell Health: How Stable Disease Describes Cancer Treatment
- American Cancer Society: Managing Cancer as a Chronic Illness
- Cancer Grace: Stable Disease: Good News or Bad News?
Research on Monitoring MBC
- PracticeUpdate (Create a free account to read): Monitoring MBC During Treatment
- UpToDate: Approach to Monitoring MBC by Priyanka Sharma, University of Kansas Medical Center
Last Modified on January 31, 2023
Tags:Treatment GuidelinesLiving With MBCNavigating Cancer CareScreening and TestingFrom the Experts